Your browser doesn't support javascript.
loading
Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).
Karow, Anne; Reimer, Jens; König, Hans Helmut; Heider, Dirk; Bock, Thomas; Huber, Christian; Schöttle, Daniel; Meister, Klara; Rietschel, Liz; Ohm, Gunda; Schulz, Holger; Naber, Dieter; Schimmelmann, Benno G; Lambert, Martin.
Affiliation
  • Karow A; Department of Psychiatry and Psychotherapy, Psychosis Centre, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Germany. karow@uke.de
J Clin Psychiatry ; 73(3): e402-8, 2012 Mar.
Article in En | MEDLINE | ID: mdl-22490266

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotherapy / Schizophrenia / Antipsychotic Agents / Cost-Benefit Analysis / Combined Modality Therapy / Dibenzothiazepines Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Psychiatry Year: 2012 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotherapy / Schizophrenia / Antipsychotic Agents / Cost-Benefit Analysis / Combined Modality Therapy / Dibenzothiazepines Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Psychiatry Year: 2012 Document type: Article Affiliation country: Country of publication: